Bioventus (BVS) Gross Margin (2020 - 2026)
Bioventus' (BVS) quarterly Gross Margin came in at 68.72% in Q1 2026, up 167.0% YoY from 25.74% in Q1 2025, and little changed on a QoQ basis from 68.89% in Q4 2025.
Bioventus (BVS) Gross Margin (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Gross Margin data on file, last reported at 68.72% in Q1 2026.
- Quarterly Gross Margin rose 167.0% year-over-year to 68.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 68.69% (up 124.0% YoY) and the FY2025 annual result came in at 68.33%, up 61.0% from the prior year.
- Gross Margin steadied at 68.72% in Q1 2026, from 68.89% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 69.14% in Q2 2025 to a low of 58.96% in Q4 2022.
- A 5-year average of 66.29% and a median of 67.05% in 2025 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin slumped 834 bps — and 2024, when it soared 618 bps.
- Tracing BVS's Gross Margin over 5 years: stood at 58.96% in 2022, then gained by 8 bps to 63.73% in 2023, then rose by 5 bps to 66.82% in 2024, then grew by 3 bps to 68.89% in 2025, then slipped by 0 bps to 68.72% in 2026.
- The last three Gross Margin figures came in at 68.72% (Q1 2026), 68.89% (Q4 2025), and 67.96% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 45.84% |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 68.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 68.97% |
| Mar 28, 2026 | 68.72% |
| Dec 31, 2025 | 68.89% |
| Sep 27, 2025 | 67.96% |
| Jun 28, 2025 | 69.14% |
| Mar 29, 2025 | 67.05% |
| Dec 31, 2024 | 66.82% |
| Sep 28, 2024 | 67.32% |
| Jun 29, 2024 | 68.54% |
| Mar 30, 2024 | 68.27% |
| Dec 31, 2023 | 63.73% |
| Sep 30, 2023 | 65.28% |
| Jul 1, 2023 | 65.02% |
| Apr 1, 2023 | 62.09% |
| Dec 31, 2022 | 58.96% |
| Oct 1, 2022 | 65.70% |
| Jul 2, 2022 | 68.88% |
| Apr 2, 2022 | 64.54% |
| Dec 31, 2021 | 67.30% |
| Oct 2, 2021 | 72.61% |